Should You Buy Canopy Growth in April?

Alex Carchidi, The Motley Fool
·5-min read
Should You Buy Canopy Growth in April?

Take the world of the cannabis industry, where unprofitability, 90-degree turns in corporate strategy, and crazy-fast revenue growth all the while are the norm. Canopy Growth (NASDAQ: CGC) is struggling with many of the same issues as its competitors, though it could have a competitive advantage in the form of its increasing focus on the marijuana beverages segment of the recreational market. In my view, Canopy has taken necessary action to address some of its most persistent issues, namely its unprofitability.